EU Court Revives Ineos Bid For AlphaRen Mark
A European Union court on Wednesday revived Ineos Healthcare Ltd.'s efforts to trademark the name AlphaRen for a new drug, mostly nixing a ruling that backed Teva Pharmaceutical Industries Ltd.'s challenge...To view the full article, register now.
Already a subscriber? Click here to view full article